Skip to main content
logo
Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
26.97
+0.93 (3.55%)
At close: Sep 11, 2026, 4:00 PM EDT
27.42
+0.46 (1.69%)
After-hours: Sep 11, 2026, 7:54 PM EDT

Biodesix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
102.9488.571.3249.0938.2154.51
Revenue Growth
34.46%24.08%45.30%28.46%-29.89%19.64%
Gross Profit
84.9371.7855.7536.0824.0623.99
Operating Income
-20.58-27.77-34.26-41.3-50.51-39.32
Net Income
-27.76-35.27-42.93-52.15-65.45-43.16
Earnings Per Share
-3.13-4.67-6.64-12.70-31.09-31.54
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3018.9926.2526.2843.0932.71
Total Debt
71.872.8561.9860.6931.8510.01
Net Cash (Debt)
-41.8-53.87-35.73-34.4111.2422.7
Net Cash Growth
-----50.49%-33.93%
Net Cash Per Share
-4.71-7.13-5.52-8.385.3416.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.83-23.27-48.65-22.87-44.97-28.22
Capital Expenditures
-0.41-0.26-3.23-22.92-3.3-2.24
Free Cash Flow
-20.24-23.53-51.88-45.79-48.27-30.46
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.50%81.11%78.17%73.50%62.96%44.01%
Operating Margin
-19.99%-31.37%-48.03%-84.13%-132.17%-72.14%
Pretax Margin
-26.97%-39.85%-60.19%-106.23%-171.27%-79.18%
Profit Margin
-26.97%-39.85%-60.19%-106.23%-171.27%-79.18%
FCF Margin
-19.66%-26.59%-72.74%-93.28%-126.32%-55.89%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.720.613.123.394.602.62